Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
According to a document submitted to the U.S. Securities and Exchange Commission (SEC), Supernus Pharmaceuticals officially signed an asset purchase agreement with Navitor on April 1, 2026.

According to a document submitted to the U.S. Securities and Exchange Commission (SEC), Supernus Pharmaceuticals officially signed an asset purchase agreement with Navitor on April 1, 2026.

老虎证券老虎证券2026/04/07 21:41
Show original
This move marks a significant milestone for both companies in asset trading.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AbbVie (ABBV.US) expands Oxford R&D facility in UK, betting on innovation in immunology, neuroscience, and oncology drugs

AbbVie announced on Wednesday that, as part of an investment plan exceeding 120 million pounds (approximately $161 million), the company has expanded its research and development facility in Oxford, United Kingdom.

智通财经•2026/11/04 02:51

BNB fell below $690

金色财经•2026/11/04 02:37
BNB fell below $690